Top Markets
#1 MarsCoin MarsCoin +46.67%
#2 Palladium Network Palladium Network +27.97%
#3 Siren Siren +27.76%
#4 Status Status +19.63%
#5 Useless Coin Useless Coin +18.72%
#6 Bedrock Bedrock +15.94%
#7 BankrCoin BankrCoin +15.33%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.19%
#9 Ankr Network Ankr Network +13.10%
#10 Arweave Arweave +10.04%
Coin of the day
MarsCoin MarsCoin
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Orchard Therapeutics plc Orchard Therapeutics plc

Orchard Therapeutics plc

ORTX
Classificação em ações #18159
Orchard Therapeutics plc is a biopharmaceutical firm dedicated to developing... Orchard Therapeutics plc is a biopharmaceutical firm dedicated to developing gene-based treatments for severe and often fatal rare conditions, operating across the United Kingdom, European Union, and the United States. Their innovative gene therapy strategy involves modifying a patient's own hematopoietic stem cells, converting them into a therapeutic cellular drug that can address the illness with just one dose. The company markets Strimvelis, a gammaretroviral therapy approved for treating adenosine deaminase-severe combined immunodeficiency (ADA-SCID). Orchard's clinical pipeline features several investigational therapies, including OTL-101 for ADA-SCID, OTL-200 targeting metachromatic leukodystrophy, OTL-103 for Wiskott-Aldrich syndrome, OTL-102 for X-linked chronic granulomatous disease, and OTL-300 for transfusion-dependent beta-thalassemia. Early-stage research programs encompass OTL-203 for mucopolysaccharidosis type I, OTL-201 for MPS-IIIA, and OTL-202 for MPS IIIB. Furthermore, a strategic partnership with Pharming Group N.V. covers the research, development, production, and commercialization of OTL-105, an experimental ex vivo autologous hematopoietic stem cell gene therapy designed for hereditary angioedema. Established in 2015 as Orchard Rx Limited, Orchard Therapeutics plc is headquartered in London, UK.
Preço da ação
$16.70
Última sincronização: 2024-02-02
Valor de mercado
$210.34M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
GB
Negociar Orchard Therapeutics plc (ORTX)

Categoria

Healthcare
Histórico de preços das ações de Orchard Therapeutics plc (ORTX)
Preço de fecho mais alto: $16.70 em 2024-02-01

Preço de fecho mais baixo: $140.00 em 2018-10-01
Histórico de preços das ações da Orchard Therapeutics plc de 2018 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2024 2.11%
2023 292.95%
2022 -67.24%
2021 -72.13%
2020 -65.44%
2019 -7.87%
2018 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $556.43 40.29%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 45.39%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $152.82 535.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $123.39 -8.70%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $757.71 6.76%
CH